Development of a HER1/CP2c dual-targeting biopharmaceutical for HER1-overexpressing head and neck cancer

Biomaterials Advances 2026

View at publisher
Authors: Kyu Tae Byun, Junmin Cho, Byung‐Soo Kim, Inbeom Lee, Eun Byeol Kim, Dongsun Park, Sang-Woo Han, Won Hyung-Sik, So Yeong Cheon, Chan Gil Kim
DOI: 10.1016/j.bioadv.2026.214782
Cited by: 0
References: 51

Fields of Study & Subjects

Monoclonal and Polyclonal Antibodies Research HER2/EGFR in Cancer Research Toxin Mechanisms and Immunotoxins

Publication details

Journal / source
Biomaterials Advances
Volume
183
Pages
214782–214782
Publication date
18 February 2026
Language
EN